259 related articles for article (PubMed ID: 19879939)
21. Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson's Disease.
Sari Y; Khalil A
CNS Neurol Disord Drug Targets; 2015; 14(6):777-85. PubMed ID: 25808895
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC
J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895
[TBL] [Abstract][Full Text] [Related]
23. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium.
Jo YS; Huong DT; Bae K; Lee MK; Kim YH
Planta Med; 2002 Jan; 68(1):84-5. PubMed ID: 11842339
[TBL] [Abstract][Full Text] [Related]
24. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
Freedland CS; Mansbach RS
Drug Alcohol Depend; 1999 May; 54(3):183-94. PubMed ID: 10372792
[TBL] [Abstract][Full Text] [Related]
25. Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition.
Jiang B; Meng L; Zou N; Wang H; Li S; Huang L; Cheng X; Wang Z; Chen W; Wang C
Phytomedicine; 2019 Sep; 62():152967. PubMed ID: 31154274
[TBL] [Abstract][Full Text] [Related]
26.
Djamshidian A; Bernschneider-Reif S; Poewe W; Lees AJ
Mov Disord Clin Pract; 2016; 3(1):19-26. PubMed ID: 30713897
[No Abstract] [Full Text] [Related]
27. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.
Herraiz T; Guillén H
Food Chem Toxicol; 2011 Aug; 49(8):1773-81. PubMed ID: 21554916
[TBL] [Abstract][Full Text] [Related]
28. Bioactive Azepine-Indole Alkaloids from
Klein-Júnior LC; Cretton S; Vander Heyden Y; Gasper AL; Nejad-Ebrahimi S; Christen P; Henriques AT
J Nat Prod; 2020 Apr; 83(4):852-863. PubMed ID: 32150413
[TBL] [Abstract][Full Text] [Related]
29. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
[TBL] [Abstract][Full Text] [Related]
30. Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from
Chaurasiya ND; Zhao J; Pandey P; Doerksen RJ; Muhammad I; Tekwani BL
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813423
[TBL] [Abstract][Full Text] [Related]
31. Metabolic fingerprinting, antioxidant characterization, and enzyme-inhibitory response of Monotheca buxifolia (Falc.) A. DC. extracts.
Ali JS; Saleem H; Mannan A; Zengin G; Mahomoodally MF; Locatelli M; Abidin SAZ; Ahemad N; Zia M
BMC Complement Med Ther; 2020 Oct; 20(1):313. PubMed ID: 33066787
[TBL] [Abstract][Full Text] [Related]
32. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
33. Polarity of extracts and fractions of four Combretum (Combretaceae) species used to treat infections and gastrointestinal disorders in southern African traditional medicine has a major effect on different relevant in vitro activities.
Ahmed AS; McGaw LJ; Elgorashi EE; Naidoo V; Eloff JN
J Ethnopharmacol; 2014 Jun; 154(2):339-50. PubMed ID: 24681040
[TBL] [Abstract][Full Text] [Related]
34. Chemical Composition of Traditional and Analog Ayahuasca.
Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A
J Psychoactive Drugs; 2021; 53(1):65-75. PubMed ID: 32896230
[TBL] [Abstract][Full Text] [Related]
35. Modulatory Effects of Alkaloid Extract from Gongronema latifolium (Utazi) and Lasianthera africana (Editan) on Activities of Enzymes Relevant to Neurodegeneration.
Nwanna EE; Adebayo AA; Oboh G; Ogunsuyi OB; Ademosun AO
J Diet Suppl; 2019; 16(1):27-39. PubMed ID: 29451813
[TBL] [Abstract][Full Text] [Related]
36. Identification and Characterization of Neuroprotective Properties of Thaumatin-like Protein 1a from
D'Errico A; Nasso R; Di Maro A; Landi N; Chambery A; Russo R; D'Angelo S; Masullo M; Arcone R
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38276545
[TBL] [Abstract][Full Text] [Related]
37. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
39. Selected chromone derivatives as inhibitors of monoamine oxidase.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
[TBL] [Abstract][Full Text] [Related]
40. Phenolic Constituents and Inhibitory Effects of Hibiscus sabdariffa L. (Sorrel) Calyx on Cholinergic, Monoaminergic, and Purinergic Enzyme Activities.
Oboh G; Adewuni TM; Ademiluyi AO; Olasehinde TA; Ademosun AO
J Diet Suppl; 2018 Nov; 15(6):910-922. PubMed ID: 29341798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
